Ligand validation:5KLZ

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 5KLZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5KLZ_AMP_B_201	75%	44%	0.117	0.95	0.92	1.23	2	2	0	0	100%	1
5ED3_AMP_B_201	98%	49%	0.055	0.975	0.86	1.1	1	1	0	0	100%	1
3TW2_AMP_A_127	96%	33%	0.058	0.969	1.02	1.62	1	3	0	0	100%	1
6J53_AMP_B_201	95%	45%	0.067	0.971	0.88	1.23	1	3	1	0	100%	1
6J58_AMP_B_201	95%	46%	0.065	0.967	0.89	1.19	1	2	0	0	100%	1
4ZKL_AMP_B_201	70%	32%	0.123	0.941	1.15	1.54	2	4	0	0	100%	0.4
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.783
3CLT_AMP_C_1262	100%	40%	0.046	0.987	0.91	1.4	1	4	0	0	100%	1
3CLR_AMP_C_1262	100%	41%	0.048	0.989	1.01	1.29	1	3	0	0	100%	1
5K99_AMP_D_101	99%	36%	0.05	0.988	1.13	1.4	2	1	0	0	100%	0.9278
5NRH_AMP_B_700	99%	34%	0.051	0.989	1.23	1.39	3	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.